REGENERON PHARMACEUTICALS, INC. Weighted Avg Shares (Diluted) 2010-2026 | REGN
What is weighted avg shares (diluted)?
Weighted average shares outstanding (diluted) includes the basic share count plus all potentially dilutive securities such as stock options, warrants, and convertible bonds. It is used as the denominator to calculate diluted earnings per share.
What is REGENERON PHARMACEUTICALS, INC.'s current weighted avg shares (diluted)?
REGENERON PHARMACEUTICALS, INC. (REGN) annual weighted avg shares (diluted) for 2025 was 108.6M, a 5.65% decline from 2024. REGENERON PHARMACEUTICALS, INC. weighted avg shares (diluted) for the quarter ending March 31, 2026 was 107.7M.
What was REGENERON PHARMACEUTICALS, INC.'s weighted avg shares (diluted) in 2024?
REGENERON PHARMACEUTICALS, INC. annual weighted avg shares (diluted) for 2024 was 115.1M, a 1.23% increase from 2023.
What was REGENERON PHARMACEUTICALS, INC.'s weighted avg shares (diluted) in 2023?
REGENERON PHARMACEUTICALS, INC. annual weighted avg shares (diluted) for 2023 was 113.7M, a 0.18% increase from 2022.
What is REGENERON PHARMACEUTICALS, INC.'s 5-year weighted avg shares (diluted) CAGR?
REGENERON PHARMACEUTICALS, INC. weighted avg shares (diluted) grew at a compound annual growth rate (CAGR) of 1.16% from FY2020 to FY2025, going from 115.1M to 108.6M over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | 108.6M | -5.6% | 10-K |
| FY2024 | 115.1M | +1.2% | 10-K |
| FY2023 | 113.7M | +0.2% | 10-K |
| FY2022 | 113.5M | +1.2% | 10-K |
| FY2021 | 112.2M | -2.5% | 10-K |
| FY2020 | 115.1M | +0.4% | 10-K |
| FY2019 | 114.6M | -0.2% | 10-K |
| FY2018 | 114.8M | -0.9% | 10-K |
| FY2017 | 115.9M | -0.3% | 10-K |
| FY2016 | 116.3M | +0.9% | 10-K |
| FY2015 | 115.2M | +1.6% | 10-K |
| FY2014 | 113.4M | +1.9% | 10-K |
| FY2013 | 111.3M | -3.5% | 10-K |
| FY2012 | 115.4M | +27.3% | 10-K |
| FY2011 | 90.6M | +9.3% | 10-K |
| FY2010 | 82.9M | - | 10-K |